Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates

Autor: T.C. Sluckin, S.J.A. Hazen, K. Horsthuis, R.G.H. Beets-Tan, I.E. Antonisse, M. Berbée, L.W. van Bockel, A.H. Boer, H.M. Ceha, J.S. Cnossen, E.D. Geijsen, M.D. den Hartogh, E.M. Hendriksen, M.P.W. Intven, M.M. Leseman-Hoogenboom, P. Meijnen, K. Muller, V. Oppedijk, T. Rozema, H. Rütten, P.H. Spruit, T.C. Stam, L.A. Velema, A.E. Verrijssen, J. Vos-Westerman, P.J. Tanis, C.A.M. Marijnen, M. Kusters
Přispěvatelé: Radiotherapy, Surgery
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: International Journal of Radiation Oncology Biology Physics. Elsevier Inc.
Dutch Snapshot Research Group 2023, ' Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates ', International Journal of Radiation Oncology Biology Physics . https://doi.org/10.1016/j.ijrobp.2023.04.013
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2023.04.013
Popis: Purpose: Involved internal iliac and obturator lateral lymph nodes (LLNs) are a known risk factor for the occurrence of ipsilateral local recurrences (LLR) in rectal cancer. This study examined coverage of LLNs with routine radiation therapy practice in the Netherlands and associated LLR rates. Methods and Materials: Patients with a primary tumor ≤8 cm of the anorectal junction, cT3-4 stage, and at least 1 internal iliac or obturator LLN with short axis ≥5 mm who received neoadjuvant (chemo)radiation therapy, were selected from a national, cross-sectional study of patients with rectal cancer treated in the Netherlands in 2016. Magnetic resonance images and radiation therapy treatment plans were reviewed regarding segmented LLNs as gross tumor volume (GTV), location of LLNs within clinical target volume (CTV), and received proportion of the planned radiation therapy dose. Results: A total of 223 out of 3057 patients with at least 1 LLN ≥5 mm were selected. Of those, 180 (80.7%) LLNs were inside the CTV, of which 60 (33.3%) were segmented as GTV. Overall, 202 LLNs (90.6%) received ≥95% of the planned dose. Four-year LLR rates were not significantly higher for LLNs situated outside the CTV compared with those inside (4.0% vs 12.5%, P =.092) or when receiving
Databáze: OpenAIRE